Home > PE Ratio > ANUH PHARMA

ANUH PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of ANUH PHARMA is 22.65.

Share Price ₹245.6Mar 28,2024
Market Cap ₹1,230.5 Cr
Earnings-TTM₹54.3 CrTTM-Standalone Results
Price/Earnings22.65xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results
ANUH PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of ANUH PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of ANUH PHARMA is calculated as :

Current Market Cap [ ₹1,230.5 Cr] as on Mar 28,2024

(/) Earnings [ ₹54.3 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 22.65x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for ANUH PHARMA , the investors are currently willing to pay 22.65 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ANUH PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of ANUH PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of ANUH PHARMA


PE Ratio Performance Analysis for ANUH PHARMA

- ANUH PHARMA 's latest p/e ratio is 22.65x.

- ANUH PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 11.70x.

- ANUH PHARMA 's operated at median p/e ratio of 11.03x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, ANUH PHARMA 's p/e ratio peaked in Mar2021 at 15.91x.

- ANUH PHARMA 's p/e ratio hit its five-year low in Mar2019 of 7.25x.


How does ANUH PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
ANUH PHARMA 54.3222.651,230.5
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6343.21388,812.0
CIPLA LTD3,744.0332.23120,673.0
DR REDDYS LABORATORIES LTD5,209.4019.71102,679.0
ZYDUS LIFESCIENCES LTD2,954.2034.24101,152.0
DIVIS LABORATORIES LTD1,382.9765.9791,234.9
MANKIND PHARMA LTD1,743.3052.7992,029.2
TORRENT PHARMACEUTICALS LTD1,494.0058.9388,034.7
LUPIN LTD1,809.7440.7473,722.0
AUROBINDO PHARMA LTD2,777.8922.9863,835.1
ABBOTT INDIA LTD1,145.5849.9857,258.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ANUH PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.71x
Max industry PE 65.97x
Median industry PE 40.74x
Average industry PE 40.31x



You may also like the below Video Courses